GRO Biosciences
PrivateLast Round
Series B
Jul 19, 2024
Est. Valuation
$90.3M
Total Funding Raised
$88.4M
Company Overview
GRO Biosciences is a biotechnology company that develops enhanced protein therapeutics using genomically recoded organisms to create biologics with non-standard amino acids for improved potency, stability, and targeted delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GRO Biosciences Comparables
Compare GRO Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pearl Bio | 87% | |
| BrickBio, Inc. | 84% | |
| Tektonyx Bio, Inc. | 82% |
GRO Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 19, 2024 | ||||
| Series A | Nov 3, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Seed | Sep 28, 2017 |
GRO Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series A |
| Access Industries | Series B |
| Digitalis Ventures | Seed, Series A, Series B |
| Innovation Endeavors | Series A, Seed, Series B |
| Atlas Venture | Series B |
| Leaps by Bayer | Series B, Series A |
| Access Biotechnology | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2024
$60M round led by Access Biotechnology, Access Industries, and Atlas Venture.
- Nov 3, 2021
$25M round led by Leaps by Bayer and Redmile Group.
GRO Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GRO Biosciences's valuation, stock price, and market status.
Is GRO Biosciences a public or private company?
GRO Biosciences is a private company.
What is the current stock price of GRO Biosciences?
GRO Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is GRO Biosciences worth (valuation)?
Valuation information for GRO Biosciences is not publicly available.
Can I buy GRO Biosciences stock?
GRO Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GRO Biosciences's last funding round?
GRO Biosciences's most recent funding round was Series B on July 19, 2024.
Who are the main investors in GRO Biosciences?
Key investors in GRO Biosciences include Redmile Group, Access Industries, Digitalis Ventures, Atlas Venture, Leaps by Bayer.
Will GRO Biosciences IPO soon?
No public IPO plans have been announced for GRO Biosciences.
How can I track GRO Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GRO Biosciences's secondary market activity and sign up for updates.